• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of heartHeartCurrent TOCInstructions to authors
Heart. Apr 2000; 83(4): 450–455.
PMCID: PMC1729356

Production of hepatocyte growth factor during acute myocardial infarction


OBJECTIVE—To investigate the clinical significance of circulating hepatocyte growth factor (HGF) and the role of peripheral blood mononuclear cells (monocytes), which are a possible source of HGF, in patients with acute myocardial infarction.
DESIGN AND PATIENTS—37 patients with acute myocardial infarction and 13 normal control subjects were recruited. Peripheral venous blood samples were drawn from the infarct patients 1, 7, 14, and 21 days after onset. Monocytes were isolated from peripheral blood at those times. HGF concentrations in serum and in a culture medium of monocytes after incubation for 24 hours (monocyte HGF levels) were measured by enzyme linked immunosorbent assay.
RESULTS—Serum HGF and monocyte HGF values within seven days after onset of myocardial infarction were significantly higher than those of control subjects and decreased by day 14. There were significant positive correlations between serum HGF and monocyte HGF levels on day 7; between maximum plasma creatine phosphokinase levels and serum HGF levels on day 1; between maximum plasma C reactive protein and serum HGF levels; and between maximum C reactive protein and monocyte HGF levels. Monocyte HGF levels were raised in the patients with progression of ventricular enlargement in the course of acute myocardial infarction.
CONCLUSIONS—Early serum HGF concentrations reflect the extent of myocardial damage in acute myocardial infarction patients. Inflammation after acute myocardial infarction is supposed to be involved in enhanced HGF production. Monocytes may play an important role in ventricular remodelling after acute myocardial infarction by releasing the cardiovascular protective mitogen HGF.

Keywords: C reactive protein; cytokines; ischaemic heart disease; remodelling; hepatocyte growth factor

Full Text

The Full Text of this article is available as a PDF (144K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984 Aug 16;122(3):1450–1459. [PubMed]
  • Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6489–6493. [PMC free article] [PubMed]
  • Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res. 1989 Jun 15;49(12):3314–3320. [PubMed]
  • Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta. 1993 Dec 23;1155(3):357–371. [PubMed]
  • Boros P, Miller CM. Hepatocyte growth factor: a multifunctional cytokine. Lancet. 1995 Feb 4;345(8945):293–295. [PubMed]
  • Miyazawa K, Shimomura T, Naka D, Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J Biol Chem. 1994 Mar 25;269(12):8966–8970. [PubMed]
  • Hamanoue M, Kawaida K, Takao S, Shimazu H, Noji S, Matsumoto K, Nakamura T. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology. 1992 Dec;16(6):1485–1492. [PubMed]
  • Igawa T, Matsumoto K, Kanda S, Saito Y, Nakamura T. Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. Am J Physiol. 1993 Jul;265(1 Pt 2):F61–F69. [PubMed]
  • Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Nakano H, et al. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J Hypertens. 1996 Sep;14(9):1067–1072. [PubMed]
  • Matsumori A, Furukawa Y, Hashimoto T, Ono K, Shioi T, Okada M, Iwasaki A, Nishio R, Sasayama S. Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction. Biochem Biophys Res Commun. 1996 Apr 16;221(2):391–395. [PubMed]
  • Nakamura Y, Morishita R, Nakamura S, Aoki M, Moriguchi A, Matsumoto K, Nakamura T, Higaki J, Ogihara T. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 1996 Sep;28(3):409–413. [PubMed]
  • Nakamura S, Moriguchi A, Morishita R, Aoki M, Yo Y, Hayashi S, Nakano N, Katsuya T, Nakata S, Takami S, et al. A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension. Biochem Biophys Res Commun. 1998 Jan 6;242(1):238–243. [PubMed]
  • Nishimura M, Ushiyama M, Nanbu A, Ohtsuka K, Takahashi H, Yoshimura M. Serum hepatocyte growth factor as a possible indicator of arteriosclerosis. J Hypertens. 1997 Oct;15(10):1137–1142. [PubMed]
  • Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. [PMC free article] [PubMed]
  • Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. [PMC free article] [PubMed]
  • Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation. 1997 Jun 3;95(11):2552–2558. [PubMed]
  • Rosen EM, Nigam SK, Goldberg ID. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol. 1994 Dec;127(6 Pt 2):1783–1787. [PMC free article] [PubMed]
  • Gillum RF, Fortmann SP, Prineas RJ, Kottke TE. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 1984 Jul;108(1):150–158. [PubMed]
  • Taniguchi T, Toi M, Tominaga T. Rapid induction of hepatocyte growth factor by heparin. Lancet. 1994 Aug 13;344(8920):470–470. [PubMed]
  • Carroll SM, White FC, Roth DM, Bloor CM. Heparin accelerates coronary collateral development in a porcine model of coronary artery occlusion. Circulation. 1993 Jul;88(1):198–207. [PubMed]
  • Sasayama S, Fujita M. Recent insights into coronary collateral circulation. Circulation. 1992 Mar;85(3):1197–1204. [PubMed]
  • Morishita R, Nakamura S, Nakamura Y, Aoki M, Moriguchi A, Kida I, Yo Y, Matsumoto K, Nakamura T, Higaki J, et al. Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes. Diabetes. 1997 Jan;46(1):138–142. [PubMed]
  • Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6489–6493. [PMC free article] [PubMed]
  • Nakamura Y, Morishita R, Higaki J, Kida I, Aoki M, Moriguchi A, Yamada K, Hayashi S, Yo Y, Matsumoto K, et al. Expression of local hepatocyte growth factor system in vascular tissues. Biochem Biophys Res Commun. 1995 Oct 13;215(2):483–488. [PubMed]
  • Lagrand WK, Niessen HW, Wolbink GJ, Jaspars LH, Visser CA, Verheugt FW, Meijer CJ, Hack CE. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation. 1997 Jan 7;95(1):97–103. [PubMed]
  • Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 3;336(14):973–979. [PubMed]
  • Pietilä KO, Harmoinen AP, Jokiniitty J, Pasternack AI. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J. 1996 Sep;17(9):1345–1349. [PubMed]
  • Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation. 1997 Dec 16;96(12):4204–4210. [PubMed]
  • Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 1994 Aug 18;331(7):417–424. [PubMed]
  • Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet. 1997 Feb 15;349(9050):462–466. [PubMed]
  • Tamura M, Arakaki N, Tsubouchi H, Takada H, Daikuhara Y. Enhancement of human hepatocyte growth factor production by interleukin-1 alpha and -1 beta and tumor necrosis factor-alpha by fibroblasts in culture. J Biol Chem. 1993 Apr 15;268(11):8140–8145. [PubMed]
  • Ohira H, Miyata M, Kuroda M, Takagi T, Tojo J, Ochiai H, Kokubun M, Nishimaki T, Kasukawa R, Obara K. Interleukin-6 induces proliferation of rat hepatocytes in vivo. J Hepatol. 1996 Dec;25(6):941–947. [PubMed]

Figures and Tables

Figure 1
Time course of serum hepatocyte growth factor (HGF) concentrations in patients with acute myocardial infarction. HGF was determined by enzyme linked immunosorbent assay as described in Methods. Serum HGF reached a peak on day 1 and decreased ...
Figure 2
(A) Hepatocyte growth factor (HGF) concentrations in the supernatant of cultured peripheral blood mononuclear cells (monocytes) in patients with acute myocardial infarction and in control subjects. Monocytes were isolated and cultured as described in ...
Figure 3
Correlations between serum hepatocyte growth factor (HGF) levels and monocyte HGF levels in patients with acute myocardial infarction: a weak correlation was found between serum HGF and monocyte HGF on day 1 after onset of (panel A, r = +0.47, ...
Figure 4
Correlations between maximum creatine phosphokinase (CPK) and hepatocyte growth factor (HGF): there was a significant positive correlation between maximum plasma CPK and both maximum serum HGF (panel A, r = +0.54, p < 0.01) ...
Figure 5
Correlations between maximum C reactive protein levels and hepatocyte growth factor (HGF) levels: there was a significant positive correlation between maximum plasma C reactive protein and maximum serum HGF (panel A, r = +0.55, p < 0.01), ...
Figure 6
Hepatocyte growth factor (HGF) levels in the patients with or without left ventricular dilatation in the course of acute myocardial infarction. We divided the patients into two groups according to the changes in left ventricular end diastolic volume ...

Articles from Heart are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...